Mary Kleppe

Person

Milford, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Target residual moisture content for lyophilized drug product
- Patent number 12,066,246
- Issue date Aug 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- Xiaolin Tang
- F26 - DRYING
Information Patent Grant
Target residual moisture content for lyophilized drug product
- Patent number 11,713,922
- Issue date Aug 1, 2023
- Regeneran Pharmaceuticals, Inc.
- Xiaolin Tang
- F26 - DRYING
Information Patent Grant
Target residual moisture content for lyophilized drug product
- Patent number 11,525,629
- Issue date Dec 13, 2022
- REGENERON PHARMACEUTICALS, INC.
- Xiaolin Tang
- F26 - DRYING

Patents Applicationslast 30 patents

Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20240393045
- Publication date Nov 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- F26 - DRYING
Information Patent Application
ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES
- Publication number 20240175027
- Publication date May 30, 2024
- Regeneron Pharmaceuticals, Inc.
- Mary Kleppe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20230358470
- Publication date Nov 9, 2023
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- F26 - DRYING
Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20230077563
- Publication date Mar 16, 2023
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20210239396
- Publication date Aug 5, 2021
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH CONCENTRATION ANTI-C5 FORMULATIONS
- Publication number 20210046182
- Publication date Feb 18, 2021
- Regeneron Pharmaceuticals, Inc.
- Mary Kleppe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mary Kleppe

Person

Patents Grantslast 30 patents

Target residual moisture content for lyophilized drug product

Target residual moisture content for lyophilized drug product

Target residual moisture content for lyophilized drug product

Patents Applicationslast 30 patents

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

HIGH CONCENTRATION ANTI-C5 FORMULATIONS